The breadth of the market favoured the declines with 685 stocks advancing and 1030 declining while 346 remained unchanged. On the BSE, 1065 stocks advanced, 1492 declined and 143 remained unchanged.
The Income Tax Department is carrying out search and seizure operations in the company's office premises and plants.
Abacavir and Lamivudine tablets are used with other antiretroviral medicines to treat Human Immunodeficiency Virus-type 1 (HIV-1) infection.
Eicher Motors, on November 14, launched Continental GT 650 & Interceptor, which are large bikes from an Indian perspective.
With this order, the company's current order book stands at 1,851 KMTs valued at Rs 166 billion.
Ajanta Pharma has received tentative approval from the US Food and Drug Administration for the generic of Vesicare.
The breadth of the market favoured the declines with 758 stocks advancing and 905 declining while 397 remained unchanged. On the BSE, 1113 stocks advanced, 1224 declined and 120 remained unchanged.
Dimethyl Fumarate delayed release capsules is a generic of Tecfidera.
HDFC MF through its Small Cap Fund acquired 2.58 percent stake (or 25 lakh equity shares) in the company on November 14.
The company's flagship product ELORES is an antiobitic medication aimed at meeting medical needs in the Antimicrobial Fiesistance (AMR) space.
Sources further said the Tata Sons board will be given an update on talks with Jet Airways.
Deutsche Bank has maintained buy call on the stock with a target at Rs 28,000 per share.
The breadth of the market favoured the advances with 843 stocks advancing and 679 declining while 520 remained unchanged. On the BSE, 880 stocks advanced, 682 declined and 66 remained unchanged.
Foreign research house Morgan Stanley has maintained equal-weight call on the stock with a target of Rs 759 per share.
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Teriflunomide tablets.
Bhatt, who was an external expert on the Search and Selection Committee (S&SC), resigned with "immediate effect" as "there may be a potential conflict of interest", the bank added.
Deutsche Bank has maintained buy rating on the stock with a target at Rs 1,320 per share.
The breadth of the market favoured the declines with 744 stocks advancing and 951 declining while 364 remained unchanged. On the BSE, 1078 stocks advanced, 1414 declined and 142 remained unchanged.
Revenue was up 4 percent at Rs 1,204 crore against Rs 1,157 crore.
The company fixed November 30, 2018 as the record date for buyback.
USFDA had conducted an inspection at the company's Bioequivalence facility located at Taloja, Maharashtra from November 8 to 14 2018.
The breadth of the market favoured the declines with 730 stocks advancing and 935 declining while 393 remained unchanged. On the BSE, 1008 stocks advanced, 1271 declined and 127 remained unchanged.
Credit Suisse cut target price of Page Industries to Rs 22,000 from Rs 26,000 per share after it reduced earnings estimates by 5-12 percent over FY19-21.
Decitabine is a generic version of Otsuka's Dacogen for Injection, 50 mg/vial, Single-Dose Vial.
Revenue of the company was up 11.6 percent at Rs 979.7 crore against Rs 878.1 crore.